Objective The purpose of this study is to investigate the incidence of determinants for
virologic failure and to identify predisposing factors to enhance treatment efficacy. Tackling …

The SARS-CoV-2 main protease (3CLpro) has an indispensable role in the viral life cycle
and is a therapeutic target for the treatment of COVID-19. The potential of 3CLpro-inhibitors …

Epidemiology of HIV drug resistance in low- and middle-incom... : Current Opinion in HIV and
AIDS Epidemiology of HIV drug resistance in low- and middle-income countries and WHO …

The SARS-CoV-2 main protease (3CLpro) is one of the promising therapeutic targets for the
treatment of COVID-19. Nirmatrelvir is the first 3CLpro inhibitor authorized for treatment of …

HIV/AIDS mortality has been decreasing over the last decade. While promising, this
decrease correlated directly with increased use of antiretroviral drugs. As a natural …

Objective: To describe our experience evaluating and initiating individuals on long-acting
injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) and evaluate factors associated with …

To evaluate the prevalence of transmitted drug resistance (TDR) to nucleoside and
nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and …

In recent years, especially as a result of war in Ukraine, enormous movements of migration
to Poland from eastern European countries have been reported, including people living with …

Objective This study aimed to determine the HIV-1 subtype distribution and HIV drug
resistance (HIVDR) in patients with ART failure from 2014 to 2020 in Hainan, China …

Background Transmitted drug resistance (TDR) is still a critical aspect for the management
of individuals living with HIV-1. Thus, its evaluation is crucial to optimize HIV care. Methods …